What is considered an optimal Omega-3 Index level?

An Omega-3 Index of 8% or higher is considered optimal, with the range of 8-12% being a reasonable target. The average American is around 5%, while populations with high fish intake, like Japan, average 9-10%. Achieving at least 8% is associated with a significantly reduced risk of all-cause mortality.

How do dietary plant-based omega-3s (ALA) compare to marine omega-3s (EPA/DHA)?

While alpha-linolenic acid (ALA) from plants is an omega-3, its conversion to EPA and especially DHA in the body is limited and varies individually, typically around 2-5% to EPA. Therefore, ALA is not considered as potent or cardio-protective as direct marine sources of EPA and DHA.

Does omega-3 supplementation increase bleeding risk, especially if on blood thinners?

Despite historical concerns related to Eskimo diets and early high-dose studies, current evidence suggests omega-3s do not cause clinically significant bleeding. The FDA states that prescription omega-3s for triglyceride lowering do not increase bleeding risk. Some studies even suggest omega-3s may subtly reduce bleeding or transfusion needs during surgery.

Can omega-3s help prevent Alzheimer's disease and other dementias?

Emerging research indicates a correlation between a higher Omega-3 Index and a reduced risk for Alzheimer's and dementia. While currently observational, the findings suggest that maintaining high omega-3 levels could be a protective factor, particularly for individuals with genetic predispositions like the APOE4 genotype.

What are the benefits of omega-3s during pregnancy?

A significant benefit of omega-3 supplementation in pregnant women is a reduced risk for premature birth, particularly early premature birth before 34 weeks. High maternal omega-3 levels are also generally linked to better long-term developmental outcomes for the child, with no observed negative effects.

Is the omega-3 to omega-6 ratio important, or should I just focus on increasing omega-3?

Dr. Harris argues that the omega-3 to omega-6 ratio is often imprecise and misleading. While balance is good, simply reducing omega-6 intake (often from healthy foods) doesn't improve health. The primary issue is typically low omega-3 intake, and the most beneficial action is to increase EPA and DHA consumption.

How do omega-3s exert their protective effects beyond lowering triglycerides?

Omega-3s are believed to be cardio-protective primarily through anti-inflammatory mechanisms. They are precursors to specialized pro-resolving mediators (SPMs) that actively shut down inflammation. They also have anti-platelet effects, making blood less likely to clot, and may improve red blood cell flexibility and oxygen delivery.

Why did some major omega-3 trials like Strength yield negative results while others like REDUCE-IT were positive?

Heterogeneity in omega-3 clinical trials stems from factors like low doses, short treatment durations, and participants already having high baseline omega-3s. REDUCE-IT used a high dose (4g EPA) successfully, while Strength, using a similar high dose, failed possibly due to the free fatty acid formulation causing chronic GI inflammation, negating benefits. Future trials should measure baseline omega-3 and only include those with low levels.

Key Moments

Dr. Bill Harris on the Omega-3 Index: Increasing Omega-3 to Promote Longevity & Transform Health

FoundMyFitness

Science & Technology4 min read111 min video

Dec 7, 2021|536,406 views|5,801|559

bill harris omega-3 research omega-3 index epa and dha fish oil reduce-it study fish oil benefits omega 3 supplements fish oil supplements fish oil side effects omega 3 index test epa and dha benefits

Save to Pod

Key Moments

TL;DR

Dr. Bill Harris discusses omega-3s, the Omega-3 Index, and their role in health and longevity.

Key Insights

Omega-3 fatty acids (EPA & DHA) offer significant health benefits, distinct from plant-based ALA.

The Omega-3 Index (EPA+DHA in red blood cells) is a reliable long-term biomarker for cardiovascular and all-cause mortality risk.

A target Omega-3 Index of 8% or higher is associated with reduced risk of cardiovascular events and improved longevity.

While omega-3s may help with bleeding times, they do not significantly increase clinically significant bleeding risk.

Sustainable sources of EPA and DHA, like algal oil and genetically modified plants, are crucial for meeting global demand.

Research suggests omega-3s play a role in brain health, including potential protection against Alzheimer's and dementia.

Omega-3s may help resolve inflammation and have shown potential benefits in reducing premature birth risk.

THE ORIGINS OF OMEGA-3 RESEARCH

Dr. Bill Harris began his extensive research on omega-3 fatty acids over 40 years ago, initially driven by an interest in how dietary fats affect cholesterol levels. A pivotal study in the late 1970s, involving high doses of fish oil, unexpectedly revealed a significant reduction in triglycerides. This finding, along with earlier work linking omega-3s to reduced atherosclerosis in Eskimos, propelled omega-3s into a new era of scientific focus and supplement development.

EARLY DISCOVERIES AND THE OMEGA-3 INDEX

Early research, including studies on high-dose fish oil, demonstrated effects on triglycerides and platelet aggregation, though cholesterol-lowering effects were later attributed to the removal of saturated fats. The concept of the Omega-3 Index emerged in 2004 from groundbreaking research showing a strong correlation between blood omega-3 levels and a significantly reduced risk of sudden cardiac arrest. This led to the development of the Omega-3 Index as a measurable and modifiable risk factor for cardiovascular health.

OMEGA-3 VS. ALA AND SUSTAINABLE SOURCES

Dr. Harris distinguishes between plant-based omega-3s like ALA and marine-based EPA and DHA, noting that ALA's conversion to EPA and DHA is inefficient and varies greatly among individuals. He advocates for marine sources or algal oil for direct EPA and DHA benefits. The unsustainability of current fish supplies to meet demand highlights the importance of developing alternative sources such as microalgae and genetically engineered plants, which could offer a more sustainable future for omega-3 production.

THE OMEGA-3 INDEX: A KEY BIOMARKER

The Omega-3 Index, measuring EPA and DHA percentages in red blood cell membranes, serves as a stable, long-term indicator of omega-3 status, analogous to HbA1c for blood sugar. Unlike plasma levels, it is less affected by daily dietary fluctuations. Studies have consistently shown that a higher Omega-3 Index is protective against cardiovascular disease and, remarkably, all-cause mortality, suggesting a systemic benefit across various health domains.

OMEGA-3'S IMPACT ON LONGEVITY AND INFLAMMATION

Recent large-scale collaborative studies involving tens of thousands of individuals have reinforced the link between a higher Omega-3 Index and a significant reduction in all-cause mortality. This protective effect extends beyond cardiovascular health to cancer and even non-cardiovascular, non-cancerous causes of death, indicating a foundational role of omega-3s in overall systemic health. The anti-inflammatory and pro-resolving properties of omega-3 metabolites are believed to be key mechanisms behind these broad benefits.

ADVANCING OMEGA-3 RESEARCH AND APPLICATIONS

Ongoing research is exploring omega-3s' role in brain health, including potential protection against Alzheimer's and dementia, particularly in individuals with genetic predispositions. Furthermore, studies in pregnant women suggest that optimizing omega-3 status can reduce the risk of premature birth and support infant development. Despite challenges in trial design and interpretations, the consistent evidence points to omega-3s as crucial nutrients for health across the entire lifespan.

INNOVATIONS IN TRIAL DESIGN AND DOSING

The heterogeneity in omega-3 research outcomes is often attributed to factors like low doses, insufficient trial durations, insufficient baseline measurements, and population background omega-3 levels. Dr. Harris advocates for more rigorous trial designs that include baseline omega-3 index measurements, exclude participants with already high levels, and analyze results based on achieved blood levels rather than just group assignment. This approach could clarify the efficacy of omega-3 interventions across different populations and conditions.

SPECIAL CONSIDERATIONS AND FUTURE DIRECTIONS

While high doses of omega-3s have shown promise, potential side effects like atrial fibrillation, observed in some high-dose trials, warrant careful consideration and further investigation, especially in individuals with pre-existing heart conditions. The complexity of omega-3 metabolism and function continues to be explored, with research delving into its impact on LDL particle size, red blood cell flexibility, and the resolution of inflammation, underscoring the multifaceted benefits of these essential fatty acids.

Mentioned in This Episode

●Supplements

●Companies

●Organizations

●Studies Cited

●Concepts

●People Referenced

Omega-3 Index Levels in Different Populations

Data extracted from this episode

Population	Average Omega-3 Index (EPA+DHA as % of total red cell fatty acids)	Average Daily Omega-3 Intake
Average Americans	~5%	100-150 mg
Japanese	8-10% (avg. 9%)	~900 mg
Vegans	~3.5%	Unknown
U.S. Military Personnel	~3.5%	Unknown
Target Optimal (Dr. Harris/OmegaQuant)	8-12%	Unknown (requires supplementation/high fish intake)
Dolphin (SeaWorld)	18-19%	Fish-only diet

Omega-3 Index and Mortality Risk Comparison (Framingham Study)

Data extracted from this episode

Lifestyle/Omega-3 Status	10-Year Risk of Mortality
Smoker + Low Omega-3	50% chance of dying
Non-Smoker + Low Omega-3	~30% chance of dying
Smoker + High Omega-3	~30% chance of dying
Non-Smoker + High Omega-3	~10% chance of dying

Common Questions

The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes, serving as a stable, long-term marker of omega-3 status. Dr. Harris developed it as an important, modifiable risk factor for various diseases, similar to cholesterol or blood pressure. People with higher Omega-3 Index levels generally have better health outcomes.

Topics

ALA Omega-6 Fatty Acids Triglycerides Omega-3 Index Fish Oil Nutrition Research Blood Thinners Premature Birth Sustainable Seafood

Mentioned in this video

pharmaceuticalIcosapent ethyl (Vascepa)

An EPA-only ethyl ester prescription omega-3 indicated for reducing cardiovascular events, with FDA stating it does not cause clinically significant bleeding.

personRonald Krauss

A researcher known for his work on small, dense LDL particles, which are more atherogenic, and how inflammation can contribute to their formation.

companyOmegaQuant

A company founded by Dr. Bill Harris that provides testing for omega-3 index levels, using identical methods to Omegametrics in Munich.

personBill Connor

Dr. Harris's post-doc mentor in Portland, Oregon, who was interested in how dietary fat affects cholesterol; he assigned Dr. Harris to a fish oil diet study.

personClemens von Schacky

Co-published a seminal paper with Dr. Harris in 2004 on the Omega-3 Index and cardiovascular disease risk, and founded Omegametrics in Munich.

supplementSalmon Oil

Used in early studies at very high doses (half a cup daily, roughly 20-25 grams of omega-3 including three salmon steaks) to investigate its effects on cholesterol and triglycerides.

studyFramingham Studies

Cohorts mentioned in research collaborations, used to study the correlation of omega-3 index with all-cause mortality, cardiovascular mortality, cancer mortality, and inflammatory biomarkers.

studyREDUCE-IT trial

A highly successful omega-3 trial using 4 grams of EPA (Vascepa), which showed a 25% reduction in cardiovascular events and identified the achieved omega-3 level as the strongest predictor of benefit.

organizationFatty Acid Research Institute (FARI)

An institute started by Dr. Bill Harris that aims to understand the health effects of various fatty acids, including omega-3s.

supplementAlgal Oil

The best source of EPA and DHA for vegetarians and vegans, derived from microalgae that naturally produce these fatty acids.

conceptHemoglobin A1c (HbA1c)

Used as an analogy to explain the stability and long-term reflection of red blood cell omega-3 index compared to plasma glucose, indicating sustained status.

supplementLinoleic Acid

An omega-6 fatty acid found in vegetable oils; research suggests higher biomarker levels are associated with lower risk for cardiovascular disease and diabetes, challenging the 'omega-6 is bad' narrative.

studyPhysicians' Health Study

An observational study where stored blood samples showed higher omega-3 levels were associated with a 90% lower likelihood of sudden cardiac death.

personCharles Serhan

The scientist who discovered specialized pro-resolving mediators (SPMs) derived from EPA and DHA, which suppress and resolve inflammation.

personChristina Jackson

Dr. Harris's daughter, a PhD and registered dietitian interested in the role of omega-3 in development, particularly for pregnant and lactating women.

studyThe SELECT Trial

A 2013 trial that examined prostate cancer incidence in men given alpha-tocopherol or selenium; a controversial sub-analysis claimed a correlation between omega-3 levels and increased prostate cancer risk, but the study design was confounded and results were not confirmed.

studyStrength Study

A large omega-3 trial (13,000 people) with similar patient profiles to REDUCE-IT, using Epanova, that found no cardiovascular benefits and was stopped early for futility, surprising many in the field.

conceptAPOE4 genotype

A genetic predisposition for Alzheimer's and dementia; research is exploring if higher omega-3 levels offer greater preventative power in individuals with this genotype.

conceptRed Cell Distribution Width (RDW)

A metric from a complete blood count that measures the variation in red blood cell sizes; a high RDW is a strong predictor of adverse outcomes, and high omega-3 is correlated with a healthier (lower) RDW.

pharmaceuticalEpanova

A formulation of EPA + DHA free fatty acids (not ethyl esters), used in the Strength study. Designed for better absorption but potentially caused GI irritation, possibly contributing to the study's negative results.

studyCochrane Report (Omega-3 in Pregnancy)

A meta-analysis of 70 trials that concluded omega-3 supplementation significantly reduces the risk of premature birth, especially early premature birth (before 34 weeks).

personJorn Dyerberg

Referred to as the 'real founder of the omega-3 story' during a past Omega Matters podcast episode, highlighting his pioneering work on omega-3s.